The abstract is read at the publisher; the summary is JClub's.
Immunoscore stratifies HPV-associated oropharyngeal cancer in an international multicenter cohort, with IS-Low linked to worse disease-free survival (HR 9.03; P < .001).
- Why it matters: Current TNM- and smoking-based risk grouping does not capture tumor biological heterogeneity in HPV-associated OPSCC, limiting more precise prognostic guidance.
- What they did: The study analyzed 191 HPV-associated (p16+ and HPV DNA/RNA+) OPSCC patients across one training cohort (n = 48) and three validation cohorts (n = 48, 50, 45), quantifying CD3+ and CD8+ densities in tumor cores and invasive margins.
- The result: IS-High showed superior 3-year DFS across cohorts (all log-rank P < .05), and adding IS to clinical variables improved DFS prediction (C-index 0.82 vs 0.70; P < .0001), with parallel patterns for TTR and OS.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.